BIM
AMRI

Bogle Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

Bogle Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-523,914
Closed -$9.74M – 421
2014
Q1 		$9.74M Buy
+523,914
New +$7.21M 0.67% 59
2013
Q4 		– Sell
-279,630
Closed -$3.6M – 399
2013
Q3 		$3.6M Sell
279,630
-145,425
-34% -$1.79M 0.37% 106
2013
Q2 		$5.04M Buy
+425,055
New +$4.6M 0.62% 64

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Bogle Investment Management's AMRI Position: Q2 2014 in Review

Bogle Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q2 2014, closing a stake of 523,914 shares — an estimated $9.74M sold.

Bogle Investment Management first reported a position in AMRI in Q2 2013 and held it in 3 quarters. The position peaked at $9.74M in Q1 2014. 132 funds tracked by Wall St. Rank hold AMRI as of Q2 2014.

  • Bogle Investment Management reported no remaining Albany Molecular Research Inc position as of Q2 2014 after selling out during the quarter.
  • Bogle Investment Management sold 523,914 Albany Molecular Research Inc shares in Q2 2014, an estimated $9.74M.
  • Bogle Investment Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 3 quarters.
  • Bogle Investment Management's Albany Molecular Research Inc position peaked at $9.74M in Q1 2014.
  • 132 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2014.

Based on Bogle Investment Management's 13F filing for Q2 2014, filed 14 Aug 2014.